$3M for IntelligentMDx

6/29/09Follow @wroush

IntelligentMDx, a Cambridge, MA, startup developing DNA- and RNA-based tests for a range of human diseases, announced last week that it has raised an additional $3 million from a group of unnamed, non-venture investors. The new funding brings the startup’s total capital pot to $26.5 million.

Wade Roush is a contributing editor at Xconomy. Follow @wroush

By posting a comment, you agree to our terms and conditions.